Core Laboratories (CLB) Cost of Revenue (2022 - 2026)

Core Laboratories' Cost of Revenue history runs 5 years deep, the most recent figure standing at $76.1 million for Q1 2026.

• On a quarterly basis, Cost of Revenue rose 4.3% year-over-year to $76.1 million in Q1 2026; TTM through Mar 2026 was $73.6 million, a 75.16% decrease from a year earlier, with the FY2025 full-year figure at $115.4 million, down 61.19% from the prior year.
• Cost of Revenue rose to $76.1 million in Q1 2026 per CLB's latest filing, from -$106.5 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $76.1 million in Q1 2026 and bottomed at -$106.5 million in Q4 2025.
• The 5-year median for Cost of Revenue is $67.9 million (2022), against an average of $37.6 million.
• Across the five-year window, Cost of Revenue tumbled 409.05% in 2023 and soared 178.46% in 2024, its largest moves.
• Year by year, Cost of Revenue stood at $30.2 million in 2022, then tumbled by 409.05% to -$93.2 million in 2023, then jumped by 178.46% to $73.1 million in 2024, then sank by 245.69% to -$106.5 million in 2025, then surged by 171.44% to $76.1 million in 2026.
• Per Business Quant, the three latest CLB Cost of Revenue figures stand at $76.1 million (Q1 2026), -$106.5 million (Q4 2025), and $30.0 million (Q3 2025).